DK1203812T3 - Svækkede pestivira - Google Patents

Svækkede pestivira

Info

Publication number
DK1203812T3
DK1203812T3 DK02003407T DK02003407T DK1203812T3 DK 1203812 T3 DK1203812 T3 DK 1203812T3 DK 02003407 T DK02003407 T DK 02003407T DK 02003407 T DK02003407 T DK 02003407T DK 1203812 T3 DK1203812 T3 DK 1203812T3
Authority
DK
Denmark
Prior art keywords
attenuated pestiviruses
pestiviruses
attenuated
Prior art date
Application number
DK02003407T
Other languages
Danish (da)
English (en)
Inventor
Gregor Meyers
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of DK1203812T3 publication Critical patent/DK1203812T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13Tumour cells, irrespective of tissue of origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK02003407T 1998-06-05 1999-05-26 Svækkede pestivira DK1203812T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110356A EP0965639A1 (de) 1998-06-05 1998-06-05 Attenuierte Pestiviren
EP99926430A EP1084251B1 (de) 1998-06-05 1999-05-26 Attenuierte pestiviren

Publications (1)

Publication Number Publication Date
DK1203812T3 true DK1203812T3 (da) 2006-04-10

Family

ID=8232074

Family Applications (3)

Application Number Title Priority Date Filing Date
DK02003407T DK1203812T3 (da) 1998-06-05 1999-05-26 Svækkede pestivira
DK99926430T DK1084251T3 (da) 1998-06-05 1999-05-26 Svækkede pestivira
DK02003408T DK1203813T3 (da) 1998-06-05 1999-05-26 Svækkede pestivira

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK99926430T DK1084251T3 (da) 1998-06-05 1999-05-26 Svækkede pestivira
DK02003408T DK1203813T3 (da) 1998-06-05 1999-05-26 Svækkede pestivira

Country Status (23)

Country Link
EP (5) EP0965639A1 (de)
JP (3) JP4632540B2 (de)
KR (1) KR100637940B1 (de)
CN (2) CN100374563C (de)
AR (3) AR020084A1 (de)
AT (3) ATE316380T1 (de)
AU (1) AU769823C (de)
BR (2) BRPI9917787B1 (de)
CA (1) CA2330241C (de)
CO (1) CO5050392A1 (de)
CZ (3) CZ301494B6 (de)
DE (3) DE69928700T2 (de)
DK (3) DK1203812T3 (de)
ES (3) ES2253457T3 (de)
HU (3) HU228469B1 (de)
NZ (1) NZ509228A (de)
PE (1) PE20000552A1 (de)
PL (2) PL202509B1 (de)
PT (2) PT1084251E (de)
SI (3) SI1203812T1 (de)
SK (3) SK287014B6 (de)
TR (3) TR200103666T2 (de)
WO (1) WO1999064604A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
EP1104676A1 (de) * 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Sichere abgeschwächte Rinderdiarrhöeviren zur Verwendung in trächtigen Kühen
ATE322541T1 (de) * 2000-04-21 2006-04-15 Akzo Nobel Nv Pestivirus mutanten und dessen enthaltende impfstoffe
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
AR069087A1 (es) 2007-10-29 2009-12-30 Boehringer Ingelheim Vetmed Cepa bacteriana de m. bovis atenuada avirulenta obtenida por pases, vacuna de micoplasma boris y metodos de uso de la misma
UY31930A (es) 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
NZ591950A (en) 2008-10-31 2012-12-21 Boehringer Ingelheim Vetmed Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
CN101915837B (zh) * 2010-07-28 2013-07-03 中国兽医药品监察所 一种猪瘟兔化弱毒活疫苗效力检验方法
WO2012038454A1 (en) 2010-09-21 2012-03-29 Intervet International B.V. Bvdv vaccine
CN103882051B (zh) * 2014-03-20 2016-04-06 北京市农林科学院 一种检测猪瘟病毒抗体的elisa方法及检测试剂盒
EP3956439A4 (de) * 2019-04-18 2023-05-03 Boehringer Ingelheim Vetmedica (China) Co., Ltd. Rekombinantes klassisches schweinefiebervirus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3752389T2 (de) * 1986-01-27 2007-06-14 Schering-Plough Ltd. Attenuierte Herpesviren, Herpesviren die eine Aminosäuresequenz kodierende fremde DNA enthalten, und diese enthaltende Impfstoffe

Also Published As

Publication number Publication date
EP0965639A1 (de) 1999-12-22
SI1203812T1 (sl) 2006-04-30
BRPI9917787B1 (pt) 2016-09-06
JP4632540B2 (ja) 2011-02-16
SK18232000A3 (sk) 2001-05-10
DK1084251T3 (da) 2005-04-11
DE69929544D1 (de) 2006-04-13
JP2010259445A (ja) 2010-11-18
CZ301569B6 (cs) 2010-04-21
AR020084A1 (es) 2002-04-10
HU228471B1 (en) 2013-03-28
HUP0102707A2 (hu) 2001-11-28
DK1203813T3 (da) 2006-05-22
WO1999064604A3 (en) 2000-01-27
JP5755265B2 (ja) 2015-07-29
TR200103664T2 (tr) 2002-06-21
ES2257476T3 (es) 2006-08-01
NZ509228A (en) 2003-12-19
JP5247770B2 (ja) 2013-07-24
JP2002517250A (ja) 2002-06-18
PT1203813E (pt) 2006-06-30
CZ301570B6 (cs) 2010-04-21
SI1084251T1 (de) 2005-08-31
EP1203813A3 (de) 2004-02-04
BR9911619A (pt) 2001-10-02
PL202161B1 (pl) 2009-06-30
BR9911619B1 (pt) 2013-11-12
TR200103666T2 (tr) 2002-03-21
ATE316380T1 (de) 2006-02-15
CZ301494B6 (cs) 2010-03-24
SK287014B6 (sk) 2009-09-07
HU228468B1 (en) 2013-03-28
WO1999064604A2 (en) 1999-12-16
ES2253457T3 (es) 2006-06-01
EP1203812A3 (de) 2004-02-04
ATE311193T1 (de) 2005-12-15
ATE286131T1 (de) 2005-01-15
AU769823C (en) 2004-11-25
PT1084251E (pt) 2005-03-31
KR20010071406A (ko) 2001-07-28
AU769823B2 (en) 2004-02-05
DE69928700T2 (de) 2006-06-22
AU4369299A (en) 1999-12-30
SK287625B6 (sk) 2011-04-05
ES2235488T3 (es) 2005-07-01
CN1304452A (zh) 2001-07-18
DE69928700D1 (de) 2006-01-05
EP1203813A2 (de) 2002-05-08
EP1203813B1 (de) 2006-01-25
CN101085346A (zh) 2007-12-12
CN100374563C (zh) 2008-03-12
PL348019A1 (en) 2002-05-06
HU228469B1 (en) 2013-03-28
AR071880A2 (es) 2010-07-21
EP1614423A2 (de) 2006-01-11
CA2330241A1 (en) 1999-12-16
PE20000552A1 (es) 2000-07-14
CZ20004533A3 (cs) 2001-07-11
PL202509B1 (pl) 2009-06-30
KR100637940B1 (ko) 2006-10-23
DE69929544T2 (de) 2006-07-20
TR200003622T2 (tr) 2001-06-21
JP2013099357A (ja) 2013-05-23
EP1203812A2 (de) 2002-05-08
SI1203813T1 (sl) 2006-06-30
EP1614423A3 (de) 2008-01-30
DE69922953T2 (de) 2005-05-19
DE69922953D1 (de) 2005-02-03
EP1084251B1 (de) 2004-12-29
SK287626B6 (sk) 2011-04-05
HUP0102707A3 (en) 2008-04-28
AR071881A2 (es) 2010-07-21
CO5050392A1 (es) 2001-06-27
EP1203812B1 (de) 2005-11-30
CA2330241C (en) 2010-09-21
EP1084251A2 (de) 2001-03-21

Similar Documents

Publication Publication Date Title
DE59902737D1 (de) Zweikomponentenbehälter
ATE341990T1 (de) Sigmidoskop
DE59912684D1 (de) Folienförmige wirkstoffträger
DE69929544D1 (de) Attenuierte Pestiviren
ATE262513T1 (de) Benzoylpyridazine
DE59902536D1 (de) Zweikomponentenbehälter
DE69800992T2 (de) Fritiergerät
NO20010660D0 (no) Isolator
IS5799A (is) FKBP latar
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
DE1118098T1 (de) Mehrfachflussigelektrosprühschnittstelle
DE19842103B4 (de) Stanznietzuführung
DE29806607U1 (de) Fritieranlage
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
PT1076660E (pt) (4-bromopirazol-3-il)-benzazolos substituidos
DE29811713U1 (de) Bauelement
DE69912869D1 (de) Selbstinduktives Bauelement
DE29819079U1 (de) Kombuchalyophilisat
ATA126298A (de) Verpuffungsklappe
DE19983031T1 (de) Kochvorrichtung
DE29807387U1 (de) Schließe
DE59900975D1 (de) Falzwalzenlagerung
DE29802605U1 (de) Etagère
DE29820409U1 (de) Jätharke